Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes to worsening metabolic health and an increased risk of type 2 diabetes.

The incretin-based therapies reduced mortality and hospitalization risk in individuals with heart failure with preserved ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

You were never warned your biology would change overnight… but today, science shows there's a faster, easier way to get back in shape at any age.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...